Low Molecular Weight Heparin for VTE prophylaxis ingredient specific

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 3
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2016-03-31T01:00:12-04:00",
  "meta" : {
    "versionId" : "10",
    "lastUpdated" : "2016-03-31T01:00:12.000-04:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "TJC EH Steward",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: Low Molecular Weight Heparins (LMWH) for VTE prophylaxis as independent ingredients for use in noting the most general idea of this type of therapy. Initial use is for representation of a medication \"not done\". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of LMWHs for VTE prophylaxis),(Exclusion Criteria: None)",
  "name" : "LowMolecularWeightHeparinForVTEProphylaxisIngredientSpecific",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "67108",
      "display" : "enoxaparin",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "67109",
      "display" : "dalteparin",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "69646",
      "display" : "tinzaparin",
      "version" : "06052023"
    } ],
    "offset" : 0,
    "total" : 3,
    "identifier" : "urn:uuid:6994169d-5682-40eb-b418-9557d5d9e979",
    "timestamp" : "2023-06-29T18:20:47-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Low Molecular Weight Heparin for VTE prophylaxis ingredient specific",
  "extension" : [ {
    "valueString" : "TJC EH Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2016-03-31",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "fe96040e-9e0f-4561-a783-714ddabd50df",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1021.12"
  } ],
  "version" : "20160331"
}